Bill Text: NJ ACR59 | 2012-2013 | Regular Session | Introduced
Bill Title: Memorializes Congress to pass S.752 and H.R.1394, the "Lung Cancer Mortality Reduction Act of 2011."
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2012-01-10 - Introduced, Referred to Assembly Human Services Committee [ACR59 Detail]
Download: New_Jersey-2012-ACR59-Introduced.html
ASSEMBLY CONCURRENT RESOLUTION No. 59
STATE OF NEW JERSEY
215th LEGISLATURE
PRE-FILED FOR INTRODUCTION IN THE 2012 SESSION
Sponsored by:
Assemblywoman ANNETTE QUIJANO
District 20 (Union)
SYNOPSIS
Memorializes Congress to pass S.752 and H.R.1394, the "Lung Cancer Mortality Reduction Act of 2011."
CURRENT VERSION OF TEXT
As introduced.
A Concurrent Resolution memorializing Congress to pass S.752 and H.R.1394, the "Lung Cancer Mortality Reduction Act of 2011."
Whereas, Lung cancer is the leading cause of cancer death for both men and women in New Jersey, accounting for 2,300 deaths among men and over 2,100 deaths among women in 2007, and about 28 percent of all cancer deaths; and
Whereas, According to projections published in the Journal of Clinical Oncology in 2009 the incidence of lung cancer will increase, between 2010 and 2030, by approximately 45 percent, including a 67 percent increase among older adults and a 99 percent increase in minority communities; and
Whereas, In 2001, the Lung Cancer Progress Review Group, convened by the National Cancer Institute, stated that funding for lung cancer research was "far below the levels characterized for other common malignancies and far out of proportion to its massive health impact," and gave the "highest priority" to the creation of an integrated, multidisciplinary, multi-institutional research program, which to date has not been developed; and
Whereas, While smoking is the leading risk factor for lung cancer, research has identified other environmental risk factors including radon and asbestos, and accumulating evidence indicates that genetic factors also may influence the onset of the disease; and
Whereas, Lung cancer is the most stigmatized of all cancers and the only cancer widely blamed on patients, even though 10 to 15 percent of lung cancer patients have never smoked; and
Whereas, Early detection of lung cancer could save more than 70,000 lives per year in the United States, according to an actuarial analysis published in the journal Population Health Management in 2009; and
Whereas, A comprehensive mortality reduction program coordinated by the United States Secretary of Health and Human Services is justified and necessary to adequately address all aspects of lung cancer and reduce lung cancer mortality among current smokers, former smokers, and non-smokers; and
Whereas, S.752 and H.R.1394 would direct the Secretary of Health and Human Services, in consultation with other federal agencies, to implement a comprehensive program to achieve a 50 percent reduction in the mortality rate of lung cancer by 2020; and
Whereas, S.752 and H.R.1394 require a strategic review of National Cancer Institute research grants, the establishment by the Food and Drug Administration of quality standards and guidelines for facilities that conduct computed tomography screening for lung cancer, and the provision of funds to the Centers for Disease Control and Prevention to establish a Lung Cancer Early Detection Program that provides low-income, uninsured, and underserved populations that are at high risk for lung cancer access to early detection services; now, therefore,
Be It Resolved by the General Assembly of the State of New Jersey (the Senate concurring):
1. The Legislature of the State of New Jersey respectfully memorializes the Congress of the United States to enact into law S.752 and H.R.1394, the "Lung Cancer Mortality Reduction Act of 2011."
2. Duly authenticated copies of this concurrent resolution, signed by the Speaker of the General Assembly and the President of the Senate, and attested by the Clerk of the General Assembly and the Secretary of the Senate, shall be transmitted to the President of the United States Senate, the Speaker of the United States House of Representatives, and each member of Congress elected from this State.
STATEMENT
This concurrent resolution memorializes Congress to pass S.752 and H.R.1394, the "Lung Cancer Mortality Reduction Act of 2011."
S.752 and H.R.1394 would require the United States Secretary of Health and Human Services (HHS) to implement a comprehensive program to achieve a 50 percent reduction in the mortality rate of lung cancer. The bill requires the program to include initiatives throughout HHS, including: (1) a strategic review and prioritization by the National Cancer Institute of research grants; (2) the establishment by the Food and Drug Administration of quality standards and guidelines for facilities that conduct computed tomography screening for lung cancer; and (3) the provision of funds to the Centers for Disease Control and Prevention to establish a Lung Cancer Early Detection Program that provides low-income, uninsured, and underserved populations at high risk for lung cancer access to early detection services. Furthermore, it requires the Secretaries of Defense and Veterans Affairs to coordinate with the Secretary of HHS in implementing coordinated care programs for military personnel and veterans diagnosed with lung cancer. It also requires the Secretary of HHS to establish: (1) the Lung Cancer Computed Tomography Screening and Treatment Demonstration Project; and (2) the Lung Cancer Advisory Board to monitor the programs established under the bill.
